| Metser, Ur |
NCT04644822: Safety and Efficacy of [18F]PSMA-1007 Injection in Suspected Persistent or Recurrent Prostate Cancer. |
|
|
| Completed | 3 | 100 | Canada | [18F] PSMA-1007 Injection | Centre for Probe Development and Commercialization, McDougall Scientific Ltd. | Prostate Cancer Recurrent, Recurrent Prostate Cancer | 01/24 | 01/24 | | |
PET ABC, NCT02751710: Impact of 18F-FDG PET-CT Versus Conventional Staging in the Management of Patients Presenting With Clinical Stage III Breast Cancer |
|
|
| Completed | N/A | 369 | Canada | Whole-body FDG PET-CT alone | Ontario Clinical Oncology Group (OCOG), Cancer Care Ontario | Stage III Breast Cancer (T0N2, T1N2, T2N2, T3N1, 2 or T4), Stage IIb Breast Cancer (T3N0) | 03/23 | 03/23 | | |
NCT03873870: 68Ga-DOTATATE PET for Management of Neuroendocrine Tumors |
|
|
| Completed | N/A | 1916 | Canada | 68Ga -DOTATATE PET scans | University Health Network, Toronto | Neuroendocrine Tumors | 04/23 | 04/23 | | |
PET MUSE, NCT02462239: Impact of Positron Emission Tomography (PET) Imaging in Muscle-invasive Urothelial Carcinoma of the Bladder Staging |
|
|
| Completed | N/A | 292 | Canada | Whole-body FDG PET-CT, PET-CT imaging | Ontario Clinical Oncology Group (OCOG), Cancer Care Ontario | Muscle-invasive Bladder Cancer | 03/24 | 11/24 | | |
NCT04804371: Dual Tracer (68Ga-DOTATATE and 18F-FDG) PET Imaging in G2 & G3 Gastroenteropancreatic Neuroendocrine Tumors |
|
|
| Active, not recruiting | N/A | 40 | Canada | F18-FDG | University Health Network, Toronto, Canadian Neuroendocrine Tumour Society (CNETS) | Neuroendocrine Tumors | 02/25 | 02/25 | | |
NCT03718260: PSMA-PET Registry for Recurrent Prostate Cancer |
|
|
| Recruiting | N/A | 3070 | Canada | [18F]-DCFPyL PET/ CT scan (PSMA PET) | Lawson Health Research Institute, Cancer Care Ontario, Centre for Probe Development and Commercialization | Recurrent Prostate Cancer | 03/24 | 12/25 | | |
| Recruiting | N/A | 160 | Canada | PET | University Health Network, Toronto | Cognitive Impairment | 12/26 | 12/26 | | |
| Downar, James |
| Not yet recruiting | 3 | 40 | Canada | Modafinil, Provigil, Placebo | Ottawa Hospital Research Institute, The Ottawa Hospital, Bruyere Research Institute | Cancer-related Cognitive Difficulties, Cancer-related Problem/Condition, Fatigue | 03/26 | 03/26 | | |
NCT04754061: PSilocybin for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL) |
|
|
| Recruiting | 1/2 | 20 | Canada | Psilocybin | Ottawa Hospital Research Institute, Bruyere Research Institute, The Ottawa Hospital, St. Joseph's Healthcare Hamilton, CHU de Quebec-Universite Laval, Centre de recherche du Centre hospitalier universitaire de Sherbrooke, Jewish General Hospital, William Osler Health System, Queen's University | Depression, Anxiety, Distress, Emotional | 01/25 | 06/25 | | |
NCT04824144: Effects of Dexmedetomidine in Patients With Agitated Delirium in Palliative Care |
|
|
| Recruiting | 1/2 | 50 | Canada | Dexmedetomidine Hydrochloride, Dexmedetomidine, Precedex | Bruyere Research Institute, The Ottawa Hospital, Bruyère Continuing Care, Foothills Medical Centre | Hyperactive Delirium, Delirium of Mixed Origin | 01/25 | 03/25 | | |
NCT04588415: Supporting Family Members With Severe Grief Reaction During the COVID-19 Pandemic |
|
|
| Enrolling by invitation | N/A | 200 | Canada | Bereavement Virtual Support Group | Ottawa Hospital Research Institute | Bereavement, Severe Grief Reaction | 12/21 | 01/22 | | |
| Terminated | N/A | 12 | Canada | Education, Bereavement support, social, and SGR risk assessment | Ottawa Hospital Research Institute, Canadian Virtual Hospice | Severe Grief Reaction | 02/24 | 02/24 | | |
NCT04257227: Transcranial Magnetic Stimulation for Psychological Distress in Patients With Advanced Illness |
|
|
| Recruiting | N/A | 15 | Canada | repetitive Transcranial Magnetic Stimulation (rTMS), intermittent theta burst stimulation (iTBS) | Ottawa Hospital Research Institute, Lotte & John Hecht Memorial Foundation, Bruyere Research Institute, Canadian Cancer Society (CCS) | Depressive Symptoms, Depression, Anxiety, Psychological Distress, Terminal Illness | 01/25 | 01/25 | | |
| MacMilan, Thomas |
| No trials found |
| Wu, Peter |
| No trials found |
| Cavalcanti, Rodrigo |
| No trials found |
